Discontinued — last reported Q3 '25
Equity
Share-Based Payment - Unrecognized Cost of Nonvested Awards
STERIS Share-Based Payment - Unrecognized Cost of Nonvested Awards decreased by 22.1% to $54.60M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 9.6%, from $60.40M to $54.60M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2019
Last reportedQ3 2025
How to read this metric
An increase suggests higher future non-cash compensation expenses, which may impact future operating margins.
Detailed definition
This represents the total compensation expense for stock-based awards that has been granted but not yet recognized in th...
Peer comparison
Common in large-cap companies that utilize equity-based compensation to align employee and shareholder interests.
Metric ID:
share_based_payment_unrecognized_costHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $67.60M | $61.08M | $66.72M | $88.11M | $80.18M | $72.01M | $99.50M | $83.01M | $68.67M | $93.97M | $75.90M | $60.40M | $88.40M | $70.10M | $54.60M |
| QoQ Change | — | -9.6% | +9.2% | +32.1% | -9.0% | -10.2% | +38.2% | -16.6% | -17.3% | +36.8% | -19.2% | -20.4% | +46.4% | -20.7% | -22.1% |
| YoY Change | — | — | — | +30.3% | +31.3% | +7.9% | +12.9% | +3.5% | -4.6% | -5.6% | -8.6% | -12.0% | -5.9% | -7.6% | -9.6% |
Range$54.60M – $99.50M
CAGR-5.9%
Avg YoY Growth+2.7%
Median YoY Growth-5.1%
Current Streak2 quarters decline
Share-Based Payment - Unrecognized Cost of Nonvested Awards at Other Companies
Frequently Asked Questions
- What is STERIS's share-based payment - unrecognized cost of nonvested awards?
- STERIS (STE) reported share-based payment - unrecognized cost of nonvested awards of $54.60M in Q4 2025.
- How has STERIS's share-based payment - unrecognized cost of nonvested awards changed year-over-year?
- STERIS's share-based payment - unrecognized cost of nonvested awards decreased by 9.6% year-over-year, from $60.40M to $54.60M.
- What does share-based payment - unrecognized cost of nonvested awards mean?
- The amount of future compensation expense for stock awards that have been granted but not yet earned by employees.